4//SEC Filing
CHESS ROBERT 4
Accession 0000950170-24-073851
CIK 0000906709other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:02 PM ET
Size
7.5 KB
Accession
0000950170-24-073851
Insider Transaction Report
Form 4
CHESS ROBERT
Director
Transactions
- Sale
Common Stock
2024-06-14$1.20/sh−19,500$23,400→ 255,273 total
Holdings
- 2,100(indirect: by daughter)
Common Stock
- 2,100(indirect: by daughter)
Common Stock
- 2,100(indirect: by son)
Common Stock
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.19 to $1.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F3]The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001227886
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:02 PM ET
- Size
- 7.5 KB